chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I HAD THE SHOT FOR SHINGLES---GOT 'EM SHORTLY AFTER THAT/Suspected vaccination failure; I HAD THE SHOT FOR SHINGLES---GOT 'EM SHORTLY AFTER THAT; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient reported case for herself or himself. The age at vaccination was not reported. The age group was not reported, however it was captured as an adult as per vaccine indication. The patient stated that he or she had the shot for shingles and got shingles shortly after that. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Stage 4 lung disease; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 72 year old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 (Batch/Lot Number: EN6198) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in Arm Left on 19Mar2021 (Batch/Lot Number: ER8727) as DOSE 2, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced stage 4 lung disease on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included sars-cov-2 antibody test with negative result on Jul2021 and sars-cov-2 antibody test with negative result on 09Aug2021  Follow-up (12Aug2021): This is a Follow up spontaneous report from a Health Authority. A contactable 72-years-old male consumer reported for himself (patient) that: he received the Pfizer Covid19 vaccines in March both doses and he was in a clinical trail where they tested him for antibodies and the result was negative. He took another antibody test at Withheld and that result was also negative.   No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a 68 year old female patient. The patient did not have any pertinent medical history and drug reactions/allergies. The patient's concomitant medications were not reported. On 25-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, once, subcutaneous, lot # L016284, expiration date 07-AUG-2016). On an unspecified date following the vaccination, in October 2015 (on or after 25-OCT-2015), the patient developed pain, redness, bruising, and itching at the injection site. The patient sought medical attention by visiting the pharmacist. There was no treatment given for the adverse events. No laboratory tests were performed. The outcome of the events was reported as not recovered. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Patient received Hib, HepA, MMR, and Varicella vaccines on 5/8/14. Temperatures of 100 F on evening of 5/8/14. Mom gave Tylenol. Soon after, patient vomited and right after his eyes rolled back and he became floppy in his grandmother's arms. Parents deny any shaking of arms or legs or stiffness.  Mom attempted to clean vomit from his mouth and noted that his lips were blue and he wasn't breathing. Family called 911 and he was unresponsive for 1-2 minutes when they were advised to start CPR by EMS, given the report that he was not breathing.  Uncle of patient who is trained in CPR started chest compressions and gave rescue breaths for 3 minutes until the ambulance arrived.  He states the baby was breathing during CPR, but it seemed hard for him to breathe.  He also was not completely awake and only seemed to perk up towards the end of the CPR.  When EMS arrived, patient was awake and alert, CPR was not continued.  Initial O2 sat was 93%, which improved to 96% with blow-by. Patient returned to normal state and was admitted to hospital for observation. The following day 5/9/14 patient had fevers up to 39C and was discharged later that day on Tylenol as needed for fever.
03/06/2006 developed discrete macula papular rash, slightly, irritable otherwise well.
Left arm was swollen, red, hot, had induration, sore. (only in the arm) x 3 days. Pt did not take any medication.
Information has been received from a nurse. The nurse reported that she saw in Sunday's (07-FEB-2010) newspaper that a female patient had bad effects after getting GARDASIL. Attempts to verify the existence of an identifiable patient have been unsuccessful. No further information is available.
pt c/o seeing black spots in rt eye as was walking out of clinic room; sat down on chair, became pale, c/o sore throat carried to table; legs elevated; ice applied to throat; BP 90/60 & faint;
Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored VAQTA (lot # L004742, exp. date: 18-AUG-2016; strength, dosage, frequency and route unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
About 12 hours after the injection @11:30pm 02/14/2019, I started to feel very tired and cold. I started to shake as I was undressing. I felt like I could not warm up. The shaking continued until I added a tee shirt and socks and stocking cap. Then the shaking subsided and I slept. I woke up about 4:00am sweating. I removed the extra clothing I was wearing and the extra blanket on the bed. As I cooled down I started to feel better. By 10am 02/15/2019 I felt normal again and had a good appetite.
Pt began feeling dizzy 15 min after immunization. Pt felt light headed over the weekend along with heart burn. Pt still feels dizzy without vertigo.
10 minutes after i received the injection to my right arm the right side of my neck felt tingly, 25 minutes after infection the feeling moved to my lips, 40 minutes after injection my whole face felt tingly, (like pins and needles or how your face feels after Novocain). I had no issues with my tongue throat of breathing.
Had a cold/allergies for two weeks; Had a cold/allergies for two weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): US-PFIZER INC-202101627441 (Pfizer).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), HYPERSENSITIVITY (non-serious) all with onset 19Nov2021, outcome "unknown" and all described as "Had a cold/allergies for two weeks".  Additional information: One of the hosts said had a cold/allergies for two weeks, that they were unsure which one. They did not have a sore throat or fever, and sneezed at least once on the show. The other host is a hypochondriac and also thought was getting sick. Likely both individuals are vaccinated. The show released 24Jun2021. Individual has gone through approximately 75 tissues in 37 mins of episode. Approximately one full 65 tissues tissue box plus around 10 more tissues. Had listened to podcast yesterday, but did not hear this.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Bell's palsy after 7 days first dose; A regulatory report was received from a physician, concerning an unknown patient of unknown age and gender, unknown race and ethnicity, who received Moderna's COVID-19 vaccine (mRNA-1273), and experienced "Bell's palsy after 7 days first dose".  The patient's medical history was not provided. Concomitant medication reported included metformin.  On an unknown date, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (batch number: unknown), for COVID-19 infection.  On an unknown date, after 7 days from first dose, the patient developed Bell's palsy. No treatment information was reported for the event.  Action taken with second dose of mRNA-1273 in response to the event was not reported.   The outcome of the event " Bell's palsy", was unknown.; Reporter's Comments: This case concerns a patient of unknown age and gender, who experienced a serious event of Facial paralysis approximately 7 days after first dose of mRNA-1273, lot # unknown. Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Approx. 7-10 min post injection pt called husband on cell phone from vehicle. Experienced respiratory distress, difficulty swallowing/breathing stopped at local fire station and was assisted by EMT to hospital by ambulance. R arm induration 14cm x 14cm. Discharge summary states allergic reaction. msv
Received Dtap and MMR on 7/12/05 3 1/2 days later broke out in rash all over. On 7/18/05, rash still present.
Vertigo daily since November 18th. I?ve never had vertigo issues before now. The vertigo is causing migraines more frequently.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed an ataxia like gait with no rash or viral symptoms. A CT scan was negative. The reporting physician felt that the pts experience was not related to therapy with varicella virus vaccine live based on the time frame from vaccination.
pt admitted to hosp positive for COVID, sepsis, respiratory failure, AKI; started on Decadron; 100% BiPAP; transferred to ICU and emergent intubation done; ABX; pt suffered cardiac arrest with asystole; code blue initiated, but husband stopped it; pt died in the hospital
muscle pain all over body 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain all over body 2nd dose) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 037B21A) for COVID-19 vaccination.     Concomitant products included FISH OIL for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain all over body 2nd dose). At the time of the report, MYALGIA (muscle pain all over body 2nd dose) had resolved.            No medical history was provided by the reporter.  Concomitant medication included Intermittent multi-vitamin for an unknown indication. No treatment medications were reported.  The event took a day to resolve.   This case was linked to MOD-2022-450439 (Patient Link).
Patient fainted after admin - has happened in the past and we were prepared - pt is fine - remained in admin chair - 2 pharmacists were present and maintained patient position - after she regained consciousness she was given a juice and then a meal (employee of store and was found to have not eaten for roughly 7 hours prior to IMZ)  Was well at end of shift for the day, checked in at pharmacy before she left.
About an hour after I was given the shot the right side of my face swelled and went numb and tingly. My right arm became numb and tingly too. it lasted for about 4 hours. it subsided around 7pm that evening. The next day I had the same occurrence as the previous day but it lasted for about 6 hours, from around 11 am till 5pm or so.
No adverse event; repeat of her 3rd dose was given/received the 3rd dose twice and is not immunocompromised; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INCORRECT DOSE ADMINISTERED (repeat of her 3rd dose was given/received the 3rd dose twice and is not immunocompromised) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Sep-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced INCORRECT DOSE ADMINISTERED (repeat of her 3rd dose was given/received the 3rd dose twice and is not immunocompromised). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (repeat of her 3rd dose was given/received the 3rd dose twice and is not immunocompromised) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medications were provided.  Patient told her daughter that she wanted a 4th booster, the new one and found somewhere that was doing it. On Tuesday, 20-Sep-2022, patient received what she thought was her 4th booster (new one), until she received a call either this morning or yesterday from facility informing that repeat of her 3rd dose was given and she must wait 2 months to receive the Bivalent.  Patient daughter informed that she immediately told her mother to contact her healthcare provider and patient daughter is concerned for her mother as she received the 3rd dose twice and is not immunocompromised. She asks if this will cause her mother any harm, she's worried for her, because she is the only living relative, her father died when she was 9.  No treatment medications were provided.
L upper arm induration 14 x 10 1/2 cm on 12/20/03.
Received vaccines during 1pm hour. Began vomiting having diarrhea and itching all over within 10 minutes of vaccinations. Taken to ER at approx 5pm; will see family Dr. today as well. ER actually felt illness was viral and prescribed only Benadryl. Child will see family Dr. 4/15/03.
This spontaneous report was received from a medical assistant and referred to a 68-year-old female patient. The patient had no medical history. The patient's concurrent conditions included allergy to AUGMENTIN, erythromycin, LEVAQUIN, TEQUIN and latex. On 29-SEP-2017, the patient was vaccinated with an unspecified dose of PNEUMOVAX 23 intramuscularly, (dose and frequency were not reported) lot # N013521 and expiration date: 23-JAN-2019. On 30-SEP-2017, the patient experienced swelling and redness of whole upper arm down to elbow after getting vaccinated. The patient went to physician's office on 02-OCT-2017 and the symptoms were beginning resolved. The outcome of the events was also reported as recovered. No causality assessment was provided by the reporter. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1710USA002412.
tachycardia, flushing, severe hives on arm received vaccine, dizziness, palpitations
1d after receiving PCV 20 noted acute onset of shaking throughout body, tremors (no prior history), felt ill, concern for potential hypoglycemia although blood sugar in 90s at the time
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not reported. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient experienced arm pain after receiving SHINGRIX vaccine. This is 1 of the 12 linked cases, reported by same reporter.
brain stroke symptoms, intense headache, burry vision, paralysis in left vocal chord, partial paralysis in bod, pain in lt eye and swelling, couldn't walk or talk, bp spike to 200
stated a 2 month old patient received 2 doses of IPOL with no reported adverse event; Initial information was received on 01-Dec-2022 regarding an unsolicited valid non-serious case received from a non-health-care professional.  This case involves 2 months old male patient who had stated a 2 month old patient received 2 doses of ipol with no reported adverse event after receiving vaccine ipv (VERO) [Ipol].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, hepatitis b vaccine RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (Pediarix).  On an 1-Dec-2022, the patient received 2nd  dose of 0.5 ml suspect ipv (VERO) Suspension for injection (frequency: total) (lot: VIB901M and expiry date: 02-Jul-2024) (strength,: not reported) via intramuscular route in Left Thigh for Immunization (Immunisation).  On 01-Dec-2022 the patient had a non-serious event of stated a 2 month old patient received 2 doses of ipol with no reported adverse event (incorrect dose administered) (same day  latency) following the administration of ipv (VERO).  Action taken: not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This is a spontaneous report received from a contactable pharmacist. A 77-year-old female patient received PREVNAR 13 (NDC number of PREVNAR 13: 0005-1971-02, lot number: S74424, expiry date: Dec2019), via an unspecified route of administration on 02Jan2018 at 0.5 ml, single in the left arm for routine vaccination. There were no reported medical history and concomitant medications. On 03Jan2018 the day after vaccination, the patient reported an allergic reaction - left arm swelled up, itched, and was red. The events lasted for 3-4 days and then she recovered completely and the dull pain started a week after the administration in Jan2018. The outcome of the event dull pain was recovering; all other events recovered in Jan2018. The reporter stated that these events may have been caused by the PREVNAR 13 as the patient did not receive any other vaccines that day.
Information has been received from a nurse practitioner, who mentioned a magazine's article concerning a 19 year old woman who on an unspecified date was vaccinated with the first dose of GARDASIL (Lot#, expire date and route not reported). The magazine's article stated that, on an unspecified date the patient's arms hurt for 3 months so the patient decided not to complete the series. The article also stated that the patient "used to run" but the patient could not run any longer because of neurological reasons. "Used to run, but could not due neurological reasons" was considered to be disabling. Additional information has  been requested. This is one of two reports from the same source.
Wound wont stop bleeding on hand; This spontaneous case was reported by a consumer and describes the occurrence of WOUND HAEMORRHAGE (Wound wont stop bleeding on hand) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced WOUND HAEMORRHAGE (Wound wont stop bleeding on hand). At the time of the report, WOUND HAEMORRHAGE (Wound wont stop bleeding on hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. The patient stated that the wound would not stop bleeding and it has been over an hour and they have tried everything.
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (WISTER RA 27/3). The pharmacist reported that the patient subsequently failed to seroconvert. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA  Dizziness
Enlarged left cervical lymph nodes. Two palpable nodes that are hard and tender.  Measuring about  3 cm in diameter today.
Increase in pain and swelling in right calf. Previous injury had only minor pain. Pain in calf increases following vaccine and had difficulty walking. Went to ER on fourth day of continued pain. No blood clots found. Both ER doctor and follow on providers assessed the vaccine likely inflamed the injury and possibly caused surface vein problems. Motrin and icing helped reduce pain. Pain lowered back to minor by day 11.
Woke up with "red blotches" on face and neck, warm to touch, mild itching. Reports no trouble breathing, no dizziness or other symptoms noted.
Bilateral shoulder bursitis with difficulty lifting arms, bilateral shoulder pain, flare of recurrent connective tissue issues overall.
hurting on right side of face, in and around R ear; hurting on right side of face, in and around R ear; severe headache; nausea; vomiting; severe dizziness; All over body rash; This is a spontaneous report from a contactable consumer or other non hcp. A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 23Jan2021 08:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included high BP, hx of blood clots/CAD, covid-19 from 10Dec2020 to an unknown date. Concomitant medications included warfarin sodium (COUMADIN); and atorvastatin calcium (STATIN [ATORVASTATIN CALCIUM]); both taken for unspecified indications, start and stop dates were not reported. On 26Jan2021, 12:00 AM, 3 days later started hurting on right side of face, in and around R ear, severe headache/nausea/vomiting & severe dizziness. All over body rash occurred. 10 days later and lasted 3 weeks. The patient received treatment for the events: antibiotic/anti nausea/MRI/CT. The patient was hospitalized for five days for the events. The outcome of the events was not recovered. The patient underwent lab tests and procedures which included computerised tomogram: unknown results on an unspecified date, magnetic resonance imaging: unknown results on an unspecified date. The patient has not been COVID tested post vaccination.   Information on the lot/batch number has been requested.
Immun given @ 245pm, watched for 20 min following, no problems. Pt states "that evening lt elbow began hurting". C/O pain & a feeling of "elbow hot to touch". Had generalized chills, sx lasted 1 day. ASA taken for pain&chills. MD notified.